How Duly is shaking up the Indian sexual wellness market

Pay attention right here or wherever you get your podcasts.

Hey, and welcome again to Fairness, the podcast in regards to the enterprise of startups, the place we unpack the numbers and nuance behind the headlines.

That is our Wednesday present, the place we sit down with a important individual on the planet of startups or enterprise, and dig into what they’re constructing.

As we speak — forward of our relaunch of our Wednesday episode that we mentioned earlier this week — we’ve an interview to share that includes TechCrunch’s very personal Morgan Sung and Shruti Dwivedi, the co-founder and CEO of health-tech startup, Duly.

Duly took half in TechCrunch Disrupt’s 2023 Battlefield cohort, displaying a worldwide viewers its contraceptive care platform that’s initially focused on the Indian market.

Why India? The corporate cites a big, younger inhabitants within the nation with greater than 700 million individuals underneath the age of 30. Nonetheless, Duly additionally stories that fewer than 15% of Indians have entry to sexual schooling. Much more, the startup notes that condom utilization within the nation is modest at finest, and practically half of younger, single girls felt “judged when in search of contraception.”

Put that every one collectively, there’s a large market hole that Duly needs to bridge.

Sexual wellness is just not a small market, naturally, and different startups are energetic within the area. Information broke late final yr, for instance, that Evofem Biosciences — which makes Phexxi, a non-hormonal contraceptive gel — discovered a purchaser after monetary struggles. Modifications to American regulation relating to abortion make it clear that entry to contraceptive care is important for girls all over the world.

A giant due to Morgan for the interview, Mary Ann for the intro, and Theresa and Kell for the edit and manufacturing!